Arthropods vaccines

The virus was not, however, isolated until 1928, and a vaccine was first developed by the South African Max Theiler in 1939. Early attempts to eradicate the mosquito by physical means, and later through the use of insecticides like DDT, were only partially successful, and the disease is still endemic in much of West Africa and in South America, but not, surpisingly, in Asia. It has been suggested that this may be due to the fact that it closely resembles the virus that causes dengue fever, which is endemic in all of Asia. They are both arboviruses, which stands for arthropod-borne viruses, are both transmitted via the bite of a mosquito and cause a haemorrhagic illness. Survivors of dengue fever would be expected to have partial immunity (at least) to yellow fever. 

Development of Vaccines for the Control of Blood-Feeding Arthropods The Combined Use of Proteomic and Genomic Strategies... 

The rjq)id advances in immunobiology, vector biology, genomics, proteomics, and vaccine technology make it very likely that anti-arthropod and vector-blocking vaccines will become important tools for control of ectoparasitic arthropods and vector-borne infectious agents. 

---